Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 6 (2), 97-102

Clinical Applications of Hormonal Therapy in Ovarian Cancer

Affiliations
Review

Clinical Applications of Hormonal Therapy in Ovarian Cancer

Gautam G Rao et al. Curr Treat Options Oncol.

Abstract

The ovary is an endocrine organ and an end organ. Hormones and their receptors have been associated with ovarian cancer and may be related to its causation. Some data suggest that hormonal therapies may have some effect on ovarian cancer in palliative settings. No hormonal therapy is approved by the US Food and Drug Administration (FDA) for the treatment of any type of ovarian malignancy nor is it listed as an active agent by any of the authoritative compendia. Because of the endocrine associations with ovarian cancer, the minimal side effects, and demonstrated activity of hormonal therapies in other endocrine-associated malignancies, further study is needed.

Similar articles

See all similar articles

Cited by 2 articles

References

    1. Gynecol Oncol. 2002 Sep;86(3):297-301 - PubMed
    1. J Reprod Med. 1996 Jun;41(6):393-6 - PubMed
    1. Fertil Steril. 1993 Oct;60(4):672-4 - PubMed
    1. Gynecol Oncol. 2004 Jul;94(1):25-32 - PubMed
    1. Gynecol Oncol. 1986 Jul;24(3):299-308 - PubMed

MeSH terms

Feedback